Cancer cells subvert fibroblast function to promote a growth factor enriched tumor microenvironment in endocrine therapy resistant ER plus breast cancer

被引：0
|
作者：
Griffiths, Jason I.
Cosgrove, Patrick A.
Castaneda, Eric Medina
Nath, Aritro
Chen, Jinfeng
Adler, Frederick R.
Chang, Jeffrey T.
Khan, Qamar J.
Bild, Andrea H.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5693
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5693
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Adenylosuccinate lyase enzyme is essential for growth of endocrine therapy resistant ER plus breast cancer cells
    Yadav, Anil K.
    Clarke, Robert
    Sengupta, Surojeet
    CANCER RESEARCH, 2023, 83 (07)
  • [2] The impact of neoadjuvant endocrine therapy (NET) in ER plus breast cancer tumor microenvironment and metastasis
    Chondronikola, Anastasia Aristoteleia
    Anastasiadou, Dimitra
    Zintiridou, Aliona
    Duran, Camille L.
    Barth, Nicole
    Karadal-Ferrena, Burcu
    Pereira-Zambalde, Erika
    Ariyan, Lina
    Shukla, Suryansh
    Karagiannis, George S.
    Entenberg, David
    Condeelis, John S.
    Oktay, Maja H.
    CANCER RESEARCH, 2024, 84 (22)
  • [3] Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER plus Breast Cancer Cells
    Castellaro, Andres M.
    Rodriguez-Baili, Maria C.
    Di Tada, Cecilia E.
    Gil, German A.
    CANCERS, 2019, 11 (02)
  • [4] Genome-Directed Therapeutics for Endocrine Therapy Resistant ER plus Breast Cancer
    Ellis, Matthew J.
    CANCER RESEARCH, 2015, 75
  • [5] Increasing DAXX Expression in ER plus Breast Cancer Cells to Overcome Endocrine Therapy Resistance
    Osipo, Clodia
    Albain, Kathy S.
    Peiffer, Daniel
    Wyatt, Debra
    CANCER RESEARCH, 2023, 83 (05)
  • [6] PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
    Koichi Ito
    Sun Hee Park
    Igor Katsyv
    Weijia Zhang
    Carmine De Angelis
    Rachel Schiff
    Hanna Y. Irie
    npj Breast Cancer, 3
  • [7] PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
    Ito, Koichi
    Park, Sun Hee
    Katsyv, Igor
    Zhang, Weijia
    De Angelis, Carmine
    Schiff, Rachel
    Irie, Hanna Y.
    NPJ BREAST CANCER, 2017, 3
  • [8] Notch signaling in ER plus breast cancer in response to endocrine therapy agents
    Singleton, Ciera S.
    Miele, Lucio
    Crabtree, Judy S.
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Lessons for ER plus breast cancer from neoadjuvant endocrine therapy trials
    Ellis, Matthew J.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 18 - 18
  • [10] Growth factor signalling in endocrine and anti-growth factor resistant breast cancer
    Nicholson, R. I.
    Hutcheson, I. R.
    Jones, H. E.
    Hiscox, S. E.
    Giles, M.
    Taylor, K. M.
    Gee, J. M. W.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2007, 8 (03): : 241 - 253
12345